Metagenomi, Inc. share price logo

Metagenomi, Inc.

NASDAQ: MGX

$0.82

-0.01

(-1.52%)

as on

Metagenomi, Inc. Stock Performance

as on October 23, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $0.80
    $0.84
    downward going graph

    1.98%

    Downside

    2.92%

    Upside

    downward going graph

  • 52 Week's Low

    52 Week's High

    $0.77
    $3.00
    downward going graph

    5.78%

    Downside

    267.54%

    Upside

    downward going graph

Metagenomi, Inc. share price movements today

Previous Close
$0.83
Open
$0.84
Volume
528.4K
Market Cap
$31.3M
Day's Low - High
$0.80 - $0.84
52 Week Low - High
$0.77 - $3.00

Metagenomi, Inc. Historical Returns

1 Month Return
-27.77 %
3 Month Return
-33.1 %
1 Year Return
-70.64 %
3 Year Return
0 %
5 Year Return
0 %

Metagenomi, Inc. Stock Fundamentals & Key Indicators

Check Metagenomi, Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$31.3M

EPS (TTM)

-2.49

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-0.33

Industry PE ratio

-3.14

PEG Ratio

0.06

EBITDA

-88.5M

Revenue (TTM)

13.6M

Profit Margin

74.29%

Return On Equity TTM

-63.65%

Metagenomi, Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Metagenomi, Inc. with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Metagenomi, Inc. image
Metagenomi, Inc.
Buy$31.3MNA-0.3374.29%0.00%
Moderna image
Moderna
Neutral$98.1B-37.95%-30.80-12.57%0.00%
BeOne Medicines image
BeOne Medicines
StrongBuy$44.0BNA27.4787.82%0.00%
Vertex Pharmaceuticals image
Vertex Pharmaceuticals
StrongBuy$132.9B191.61%30.2886.04%0.00%
Regeneron image
Regeneron
Buy$83.1B43.11%19.2484.86%0.46%

Stock Returns calculator for Metagenomi, Inc. Stock including INR - Dollar returns

The Metagenomi, Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

Metagenomi, Inc. investment value today

Current value as on today

₹31,728

Returns

-₹68,272

(-68.27%)

Returns from Metagenomi, Inc. Stock

-₹70,640 (-70.64%)

Dollar Impact

₹2,368 (+2.37%)

Analyst Recommendation on Metagenomi, Inc. Stock

Based on 2 analysts

BUY

100.00%

Buy

0.00%

Hold

0.00%

Sell

Based on 2 analysts, 100% of analysts recommend a 'BUY' rating for Metagenomi, Inc.. Average target price of $7

Metagenomi, Inc. Share Price Target

Get share price movements and forecasts by analysts on Metagenomi, Inc..

What analysts predicted

88.34%UPSIDE

Target Price

$7

Current Price

$0.8162

Analyzed by

2 Analysts

High

$7

Target

$7.00

Low

$7

Metagenomi, Inc. target price $7, a slight upside of 88.34% compared to current price of $0.8162. According to 2 analysts rating.

Indian Investors' Interest in Metagenomi, Inc. Stock

Search interest for Metagenomi, Inc. Stock has increased by 100% in the last 30 days, reflecting an upward trend in search activity.

Time period: to

Change:100% versus previous 30 day period

Metagenomi, Inc. Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
11
20
11
9
4
8
8
3
1
0
Gross Profit
-20
20
11
9
-21
-13
7
2
0
0
Operating Income
-29
-16
-22
-20
-27
-20
-22
-24
-24
-28
EBITDA
-23
-11
-19
-23
-23
-18
-19
-21
-21
-26
Interest Expense
-
-
-
-
-
-
-
-
-
-
Depreciation
1
1
1
1
1
1
1
1
1
1
Income Before Tax
-25
-12
-20
-24
-24
-19
-20
-22
-23
-27
Income Tax Expense
-
-2
-2
-1
0
0
0
0
0
-
Net Income
-25
-10
-18
-23
-25
-19
-20
-22
-23
-27
Net Profit Margin
-181.74%
100.00%
100.00%
100.00%
-509.21%
-164.38%
84.71%
66.76%
30.85%
100.00%

Metagenomi, Inc. Annual Profit & Loss

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
0
17
44
52
25
Gross Profit
0
15
-49
52
19
Operating Income
-23
-44
-78
-88
-96
EBITDA
-20
-39
-56
-78
-82
Interest Expense
0
0
-
-
-
Depreciation
0
1
4
5
5
Income Before Tax
-21
-41
-60
-83
-87
Income Tax Expense
-
2
8
-5
0
Net Income
-21
-43
-68
-78
-87
Net Profit Margin
-59.26%
89.92%
-110.93%
100.00%
78.91%

Metagenomi, Inc. Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-25
-10
-18
-23
-25
-19
-20
-22
-23
-27
Operating Cash Flow
-29
-26
-26
-26
-22
-21
-21
-23
-21
-19
Investing Cash Flow
-94
-13
-8
28
24
19
27
32
3
33
Financing Cash Flow
86
-2
0
-
0
0
0
0
0
0
Change in Cash
-38
-41
-36
2
1
-2
5
8
-16
13

Metagenomi, Inc. Annual Cash Flow

All numbers in Millions USD

Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-21
-43
-68
-78
-87
Operating Cash Flow
24
29
-91
-109
-88
Investing Cash Flow
-74
-122
45
-88
103
Financing Cash Flow
39
239
1
84
0
Change in Cash
-10
147
-44
-113
14

Global Institutional Holdings in Metagenomi, Inc.

Check out the Institutions with significant holdings in Metagenomi, Inc..

Funds
Holdings
VANGUARD INDEX FUNDS
2.80%
Vanguard
2.80%
Bridgeway Funds, Inc.
1.03%
Fidelity Concord Street Trust
0.68%
iShares
0.23%
See all

Insights on Metagenomi, Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 671.9% return, outperforming this stock by 742.5%

  • imgNEGATIVE IMPACT

    Price Dip

    img

    In the last 1 month, MGX stock has moved down by -27.8%

  • imgNEGATIVE IMPACT

    Profit Down

    img

    Netprofit is down for the last 5 quarters, -19.90M → -27.48M (in $), with an average decrease of 8.6% per quarter

  • imgNEGATIVE IMPACT

    Revenue Fall

    img

    Revenue is down for the last 4 quarters, 8.65M → -257.0K (in $), with an average decrease of 81.2% per quarter

About Metagenomi, Inc.

Metagenomi, Inc. operates as a biotechnology company focused on gene editing, committed to developing therapeutic solutions for patients. The company utilizes a distinctive genome editing toolkit, sourced from metagenomics, for its development efforts within the United States. This advanced toolkit comprises programmable nucleases, base editors, and sophisticated RNA and DNA-mediated integration systems, notably prime editing and CRISPR-associated transposases. Metagenomi has established several key collaborations: a strategic alliance with ModernaTX, Inc. to explore new genome editing systems for in vivo human therapeutic applications; a development and licensing agreement with Affini-T Therapeutics, Inc. to create and commercialize gene-edited T-cell receptor therapies for human cancer; and a partnership with Ionis Pharmaceuticals, Inc. to research, develop, and market investigational medicines leveraging genome editing technologies. Founded in 2016, the company is based in Emeryville, California.
OrganisationMetagenomi, Inc.
Headquarters5959 Horton Street, Emeryville, CA, 94608, US
IndustryBiotechnology
CEOJian Irish

Key Management of Metagenomi, Inc.

Name

Title

Ms. Katalin Kauser M.D., Ph.D.

Senior Vice Pres­i­dent of Trans­la­tion­al Biol­o­gy

Mr. Nikhil Bhide M.B.A.

Senior Vice President of Business Development

Dr. Jian Irish M.B.A., Ph.D.

CEO, President & Director

Ms. Pamela M. Wapnick M.B.A.

Chief Financial Officer

Mr. Matthew L. Wein J.D.

Gen­er­al Coun­sel, Com­pli­ance Offi­cer, Head of BD&L and Cor­po­rate Secretary

Dr. Joseph Knowles M.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Mark Leonard

Senior Vice Pres­i­dent of Tech­ni­cal Devel­op­ment & Oper­a­tions

Dr. Alan Brooks Ph.D.

Senior Vice President of Research

FAQs

What is Metagenomi, Inc. share price today?

Metagenomi, Inc. share price today is $0.82 as on at the close of the market. Metagenomi, Inc. share today touched a day high of $0.84 and a low of $0.80.

What is the 52 week high and 52 week low for Metagenomi, Inc. share?

Metagenomi, Inc. share touched a 52 week high of $3.00 on and a 52 week low of $0.77 on . Metagenomi, Inc. stock price today i.e. is closed at $0.82,which is 72.79% down from its 52 week high and 6.14% up from its 52 week low.

What is Metagenomi, Inc.'s market capitalisation today?

Metagenomi, Inc. market capitalisation is $0.00T as on .

How to invest in Metagenomi, Inc. Stock (MGX) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Metagenomi, Inc. on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Metagenomi, Inc. Stock (MGX) from India?

Indian investors can start investing in Metagenomi, Inc. (MGX) shares with as little as ₹94.81749725341797 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹948.17 in Metagenomi, Inc. stock (as per the Rupee-Dollar exchange rate as on ). Based on Metagenomi, Inc. share’s latest price of $0.82 as on October 23, 2026 at 8:46 am IST, you will get 12.2519 shares of Metagenomi, Inc.. Learn more about fractional shares .